building a renewed image after head & neck cancer treatment (bright) 2.0

Conditions: Head and Neck Cancer

Summary: head and neck cancer (hnc) survivors with body image-related distress (bid) will be randomized to 5-weeks of tablet-based bright or tablet-based active control (ac; electronic information about hnc recovery). participants will complete validated measures of bid and psychological, social, and emotional wellbeing to assess the preliminary clinical impact of bright on bid in hnc survivors. participants will also complete validated measures of body image coping behavior to assess the role of image coping behavior as the behavioral mechanism of bright.

following screening and informed consent, eligible participants will complete baseline questionnaires measuring bid and psychological, social, and emotional wellbeing. participants (n=44) will then be randomized 1:1 to bright or ac and undergo weekly, tablet-based bright or ac for 5 weeks. the bright intervention consists of 5 weekly, 60-minute, tablet-based, one-one telehealth sessions with a licensed therapist. the control intervention will be matched to replicate the frequency, intensity, and delivery method of bright. participants in the ac arm will thus undergo 5 weekly, 60-minute, tablet-based video sessions in which they undergo non-manualized discussions with a non-trained member of the study team. following randomization, patients in each arm will receive a study-issued, cellular-enabled ipad loaded with vidyo, a video teleconference platform that allows the participant to connect to the study psychologist (bright) or ac. vidyo allows face-face communication for tele-cognitive behavioral therapy (cbt) for hnc patients who can articulate well, but also includes a within-video text message feature for aphonic (due to surgical removal of the larynx) or severely dysarthric (due to surgical removal of a significant amount of the tongue) hnc patients who are unable to participate in tele-cbt by speaking. the study ipads are locked to prevent downloading of additional applications. participants receive a pictorial instructional booklet for logging on to vidyo. no user names, logins, or web addresses are necessary to connect to the bright session. the participant simply clicks on the vidyo application which takes the participant to the assigned teleconference room. at the conclusion of the 5-week intervention, participants return ipads to the study team in pre-addressed, stamped, padded mailers that are provided to the patient.

Eligibility criteria:
inclusion criteria 1. age \> 18 years at the time of screening 2. history of pathologically confirmed invasive squamous cell carcinoma (or histologic variant) of the upper aerodigestive tract (oral cavity, pharynx, larynx, nose/paranasal sinuses), carcinoma of a major or minor salivary gland, or cutaneous malignancy of the face or neck 3. history of curative intent surgery with or without adjuvant therapy, with or without reconstruction 4. american joint committee on cancer (ajcc) 8th edition pathologic stage grouping i-iv 5. completion of oncologic treatment within 12 months of study enrollment (but no sooner than 6 weeks post-treatment completion) 6. no planned significant hnc ablative or reconstructive surgery (defined by a postoperative inpatient stay of at least three days) during the study intervention or follow-up period as determined by the hnc oncologic surgeon at the time of study accrual 7. willingness to be randomized to either bright or ac 8. body image scale (bis) score \>/= 10 exclusion criteria: 1. inability to speak or write english 2. pre-existing, ongoing cbt services for other disorders and the participant is not willing to discontinue the prior therapy for the duration of the proposed trial. 3. initiation or adjustment (\< 3 months of baseline) of psychotropic medication. 4. severe psychiatric comorbidity (e.g. suicidal ideation, psychosis)